Amgen Inc. won US approval for a new drug to treat a particularly aggressive form of advanced lung cancer, providing a badly needed new option for patients when chemotherapy stops working.
Share Sales Rebound 98% in Toronto as Copper, Gold Prices SurgePrivate Credit Titans Pack Middle East Flights to Chase BillionsMillennium, Point72 and Citadel Are Among Buyers of Bitcoin ETFsMoneyGram Joins Repricing Bonanza With $398 Million LoanBernanke and Blanchard Say Central Banks Need Cooler Job MarketsRenaissance Technologies Piled Into GameStop, AMC Ahead of RallyJane Street Ordered to Detail Secret India Trading StrategyFunds Managed by Bank Trust Departments Draw Scrutiny From SECUS...
1 Billion Deal for SilverBowThe Daily Chase: Canada's Crypto King arrested on fraud chargesU.S. core CPI cools for first time in 6 months in relief for Fed'I'm bullish on commodities': Portfolio manager on the state of the Canadian dollarStatistics Canada reports wholesale sales down 1.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Investors Pile Into Amgen in Search of Next Obesity Drug PayoutInvestors who may have missed out on the blistering rally in Eli Lilly & Co. and Novo Nordisk A/S are once again taking a chance with Amgen Inc.
Read more »
Amgen's peek at its GLP-1 drug trial results heightens competition in obesity marketCompetition is heating up in the GLP-1 space as Amgen gets closer to the finish line with its candidate.
Read more »
The two ways Amgen's new weight-loss drug can stand outPharmaceutical stock Amgen (AMGN) is rising following early positive results from the development of its new GLP-1 weight-loss drug, MariTide. Yahoo Finance ...
Read more »
Amgen surges over confidence in early obesity drug resultsShares of Amgen (AMGN) are jumping Friday morning after the company showed confidence in early results from a GLP-1 weight-loss drug that is in development...
Read more »
Novo Nordisk drops 5% after rival Amgen teases weight-loss drug dataExplore stories from Atlantic Canada.
Read more »
Novo Slides as Amgen Update Fuels Obesity Drug Competition Fears(Bloomberg) -- Novo Nordisk A/S shares slid on Friday as a US rival’s comments on an experimental obesity drug gave rise to concerns about potential new...
Read more »